A Mathematical Model for MicroRNA in Lung Cancer

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kang, Hye Won ^a   Crawford, Melissa ^b   Fabbri, Muller ^a   Nuovo, Gerard ^b   Garofalo, Michela ^a   Nana Sinkam, S Patrick ^b   Friedman, Avner ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 9; MICRORNA LET 7; MICRORNA LET 7A; MYC PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; COMPUTER MODEL; COMPUTER SIMULATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; IN VITRO STUDY; INTRACELLULAR SIGNALING; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MATHEMATICAL MODEL; PROTEIN EXPRESSION; UPREGULATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; COMPUTER SIMULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; MODELS, GENETIC; MUTATION; ONCOGENE PROTEIN P21(RAS); PROTO-ONCOGENE PROTEINS C-MYC; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84872872156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053663     Document Type: Article

References (51)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: A Cancer Journal for Clinicians.
2. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Research 64: 3753.
3. Nicoloso M, Spizzo R, Shimizu M, Rossi S, Calin G, (2009) MicroRNAs-the micro steering wheel of tumour metastases. Nature Reviews Cancer 9: 293-302.
4. Trang P, Medina P, Wiggins J, Ruffino L, Kelnar K, et al. (2009) Regression of murine lung tumors by the let-7 microRNA. Oncogene 29: 1580-1587.
5. Trang P, Wiggins J, Daige C, Cho C, Omotola M, et al. (2011) Systemic delivery of tumor suppressor microrna mimics using a neutral lipid emulsion inhibits lung tumors in mice. Molecular Therapy 19: 1116-1122.
6. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
7. Volinia S, Calin G, Liu C, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America 103: 2257.
8. Crawford M, Batte K, Yu L, Wu X, Nuovo G, et al. (2009) MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochemical and Biophysical Research Communications 388: 483-489.
9. Võsa U, Vooder T, Kolde R, Fischer K, Välk K, et al. (2011) Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes, Chromosomes and Cancer.
10. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nature Cell Biology 12: 247-256.
11. Mascaux C, Laes J, Anthoine G, Haller A, Ninane V, et al. (2009) Evolution of microRNA expression during human bronchial squamous carcinogenesis. European Respiratory Journal 33: 352.
12. Frenzel A, Lovén J, Henriksson M, (2010) Targeting MYC-regulated miRNAs to combat cancer. Genes & Cancer 1: 660.
13. Aguda B, Kim Y, Piper-Hunter M, Friedman A, Marsh C, (2008) MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proceedings of the National Academy of Sciences of the United States of America 105: 19678.
14. Yokota J, Wada M, Yoshida T, Noguchi M, Terasaki T, et al. (1988) Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Oncogene 2: 607.
15. Broers J, Viallet J, Jensen S, Pass H, Travis W, et al. (1993) Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers. American Journal of Respiratory Cell and Molecular Biology 9: 33.
16. Rapp U, Korn C, Ceteci F, Karreman C, Luetkenhaus K, et al. (2009) MYC is a metastasis gene for non-small-cell lung cancer. PLoS One 4: e6029.
17. Rinaldi A, Poretti G, Kwee I, Zucca E, Catapano C, et al. (2007) Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma. Leukemia & Lymphoma 48: 410.
18. Wolfer A, Ramaswamy S, (2011) MYC and metastasis. Cancer Research 71: 2034.
19. Inamura K, Togashi Y, Nomura K, Ninomiya H, Hiramatsu M, et al. (2007) let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis. Lung Cancer 58: 392-396.
20. Wang Z, Lin S, Li J, Xu Z, Yao H, et al. (2011) MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1 - let-7d via noncanonical e-box. Journal of Biological Chemistry 286: 39703-39714.
21. Johnson S, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
22. Lee Y, Dutta A, (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes & Development 21: 1025-1030.
23. Thuault S, Tan E, Peinado H, Cano A, Heldin C, et al. (2008) HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. Journal of Biological Chemistry 283: 33437.
24. Nawrocki-Raby B, Gilles C, Polette M, Bruyneel E, Laronze J, et al. (2003) Upregulation of MMPs by soluble E-cadherin in human lung tumor cells. International Journal of Cancer 105: 790-795.
25. Zheng S, Chang Y, Hodges K, Sun Y, Ma X, et al. (2010) Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival. Anticancer Research 30: 713-718.
26. Rao J, Gondi C, Chetty C, Chittivelu S, Joseph P, et al. (2005) Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Molecular Cancer Therapeutics 4: 1399.
27. Sulzer M, Leers M, van NOORD J, Bollen E, Theunissen P, (1998) Reduced Ecadherin expression is associated with increased lymph node metastasis and unfa29 vorable prognosis in non-small cell lung cancer. American Journal of Respiratory and Critical Care Medicine 157: 1319-1323.
28. Mitselou A, Batistatou A, Nakanishi Y, Hirohashi S, Vougiouklakis T, et al. (2010) Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites. Histology and Histopathology 25: 1257-1267.
29. Saad A, Yeap B, Thunnissen F, Pinkus G, Pinkus J, et al. (2008) Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma. Cancer 113: 2129-2138.
30. Roberts P, Der C, (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310.
31. Zhao C, Du G, Skowronek K, Frohman M, Bar-Sagi D, (2007) Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nature Cell Biology 9: 707-712.
32. Brown K, Hill C, Calero G, Myers C, Lee K, et al. (2004) The statistical mechanics of complex signaling networks: nerve growth factor signaling. Physical Biology 1: 184.
33. Orton R, Adriaens M, Gormand A, Sturm O, Kolch W, et al. (2009) Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway. BMC Systems Biology 3: 100.
34. Huang S, Ren X, Wang L, Zhang L, Wu X, (2011) Lung-cancer chemoprevention by induction of synthetic lethality in mutant KRAS premalignant cells in vitro and in vivo. Cancer Prevention Research 4: 666.
35. Zhang Z, Stiegler A, Boggon T, Kobayashi S, Halmos B, (2010) EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget 1: 497.
36. da Cunha Santos G, Shepherd F, Tsao M, (2011) EGFR mutations and lung cancer. Annual Review of Pathology: Mechanisms of Disease 6: 49-69.
37. Adjei A, (2001) Blocking oncogenic Ras signaling for cancer therapy. Journal of the National Cancer Institute 93: 1062-1074.
38. Marino S, Hogue I, Ray C, Kirschner D, (2008) A methodology for performing global uncertainty and sensitivity analysis in systems biology. Journal of Theoretical Biology 254: 178-196.
39. Stone K, Mercer R, Gehr P, Stockstill B, Crapo J, et al. (1992) Allometric relationships of cell numbers and size in the mammalian lung. American Journal of Respiratory Cell and Molecular Biology 6: 235.
40. Fujioka A, Terai K, Itoh R, Aoki K, Nakamura T, et al. (2006) Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes. Journal of Biological Chemistry 281: 8917-8926.
41. Rudolph C, Adam G, Simm A, (1999) Determination of copy number of c-Myc protein per cell by quantitative western blotting. Analytical Biochemistry 269: 66-71.
42. Luscher B, Eisenman R, (1988) c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Molecular and Cellular Biology 8: 2504.
43. Lim L, Lau N, Weinstein E, Abdelhakim A, Yekta S, et al. (2003) The microRNAs of Caenorhabditis elegans. Genes & Development 17: 991.
44. Liang Y, Ridzon D, Wong L, Chen C, (2007) Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8: 166.
45. Sethi P, Lukiw W, (2009) Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neuroscience Letters 459: 100-104.
46. Iliopoulos D, Hirsch H, Struhl K, (2009) An epigenetic switch involving NF-κ B, Lin28, let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 139: 693-706.
47. Chaplain M, (2011) Multiscale mathematical modelling in biology and medicine. IMA Journal of Applied Mathematics 76: 371.
48. Fujita Y, Krause G, Scheffner M, Zechner D, Leddy H, et al. (2002) Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nature Cell Biology 4: 222-231.
49. Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, et al. (2009) Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease. Anticancer Research 29: 2513.
50. Hopkins S, Henderson A, Levin D, Yamada K, Arai T, et al. (2007) Vertical gradients in regional lung density and perfusion in the supine human lung: the Slinky effect. Journal of Applied Physiology 103: 240-248.
51. Akool E, Kleinert H, Hamada F, Abdelwahab M, Forstermann U, et al. (2003) Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Molecular and Cellular Biology 23: 4901.